Pharmakon A/S
A/SActiveCVR 10038839Milnersvej 42, 3400 HillerødHotels and similar accommodation· NACE 5510Est. 1986 · 40 years old171 employees
Loading company…
Overview
Pharmakon A/S is a Danish A/S based in Hillerød, operating in the Hotels and similar accommodation sector. Incorporated in 1986, the company has 171 employees and reported revenue of DKK 143.5m in its latest annual filing.
Revenue 2025
143.5M DKK
+1% vs 2024
EBITDA margin
0.9 %
−80% vs 2024
Net profit 2025
-3.2M DKK
-270% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
82.2 %
Very strongAmong the 10% highest rated companies in the industry
20212025
Liquidity ratioCurrent assets ÷ Short-term debt
3.7×
Very strongAmong the 10% highest rated companies in the industry
20212025
Return on assets (ROA)Net profit ÷ Total assets × 100
-2.7 %
WeakAmong the 40% lowest rated companies in the industry
20212025
EBITDA — year on year
DKK millionsKey figures
Annual report 2025| Revenue | 143.5M DKK | +1% |
| EBITDA | 1.3M DKK | -80% |
| Net profit | -3.2M DKK | -270% |
| Total assets | 120M DKK | -5% |
| Equity | 98.6M DKK | -3% |
| Employees | 171 | — |
Company information
Legal name
PHARMAKON A/S
CVR number
10038839
Legal form
Aktieselskab
NACE code
Founded
24 February 1986 · 40 years
Share capital
DKK 20,000,000
Employees
171 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med enten et medlem af bestyrelsen eller en direktør eller af fire medlemmer af bestyrelsen i forening med en direktør eller af den samlede bestyrelse
Company purpose
Selskabets formål er at drive Farmakonomskolen, et konferencecenter samt et uddannelses- og udviklingscenter for farmaceutisk praksis, herunder:
- at drive uddannelses- og konsulentvirksomhed til ledere og medarbejdere på apotekerne i Danmark
- at udvikle informations- og uddannelsesmateriale til apotekssektoren
- at uddanne farmakonomer, herunder udvikle undervisningsmaterialer
- at drive forskning og udvikling indenfor lægemiddelanvendelse og sikker medicinering
- at levere uddannelse og konsulentbistand til den farmaceutiske industri, sygehusapoteker og deres leverandører
- at drive et konferencecenter med lokaler, værelser og faciliteter.
(no translation available)
Contact
Address
Milnersvej 42, 3400 Hillerød
Phone
+45 4820 6000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Pharmakon A/S reported revenue of DKK 143.5m, an increase of 1% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of DKK 3.2m, and the EBITDA margin stood at 0.9%.
At the end of 2025, equity financed 82.2% of the balance sheet, and current assets covered short-term debt 3.7 times.
Financials
Revenue
DKK millionsEBITDA
DKK millionsIncome statement
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 143,466 | 141,350 | 140,527 | 128,937 | 117,064 |
| Staff expenses | -93,834 | -87,861 | -83,770 | -81,607 | -75,538 |
| EBITDA | 1,349 | 6,828 | 11,682 | 9,581 | 16,325 |
| Depreciation & amort. | -6,794 | -6,397 | -6,975 | -6,787 | -6,260 |
| EBIT | -5,445 | 431 | 4,707 | 2,794 | 10,065 |
| Net financials | 1,448 | 2,192 | 1,846 | 720 | 538 |
| Profit before tax | -3,997 | 2,623 | 6,553 | 3,514 | 10,603 |
| Tax | -791 | 733 | 1,453 | 782 | 2,343 |
| Net profit | -3,206 | 1,890 | 5,100 | 2,732 | 8,260 |
Balance sheet
DKK thousands| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 120,024 | 126,373 | 126,486 | 126,878 | 125,437 |
| Equity | 98,649 | 101,855 | 99,965 | 94,865 | 92,133 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 14,785 | 17,642 | 19,520 | 24,851 | 25,954 |
| Total debt | 14,785 | 17,642 | 19,520 | 24,851 | 25,954 |
Financial ratios
5-year trendEBITDA margin
0.9 %
20212025
Equity ratio
82.2 %
Very strongAmong the 10% highest rated companies in the industry
20212025
Return on equity
-3.2 %
WeakAmong the 30% lowest rated companies in the industry
20212025
Net profit margin
-2.2 %
WeakAmong the 40% lowest rated companies in the industry
20212025
Asset turnover
1.20×
AverageAround the average of companies in the same industry
20212025
Debt / equity
0.22×
Very strongAmong the 10% highest rated companies in the industry
20212025
Sector performance
27 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Gross marginVery strong
Among the 20% highest rated companies in the industry
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginWeak
Among the 30% lowest rated companies in the industry
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginWeak
Among the 40% lowest rated companies in the industry
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Return on equity (ROE)Weak
Among the 30% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Weak
Among the 40% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Weak
Among the 30% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Weak
Among the 40% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Capacity ratioWeak
Among the 40% lowest rated companies in the industry
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current ratioVery strong
Among the 10% highest rated companies in the industry
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioVery strong
Among the 10% highest rated companies in the industry
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioStrong
Among the 40% highest rated companies in the industry
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets to equityVery strong
Among the 20% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalAverage
Around the average of companies in the same industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioVery weak
Among the 10% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Debt & solvency
Solidity ratioVery strong
Among the 10% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Debt ratioVery strong
Among the 10% highest rated companies in the industry
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityVery strong
Among the 10% highest rated companies in the industry
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Liabilities to equityVery strong
Among the 20% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Income to debtVery weak
Among the 20% lowest rated companies in the industry
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtAverage
Around the average of companies in the same industry
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageVery weak
Among the 20% lowest rated companies in the industry
The ability to pay the interest on the company's debt out of its earnings.
Interest rate on debtStrong
Among the 40% highest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginWeak
Among the 40% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Efficiency & development
Asset turnoverAverage
Around the average of companies in the same industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Equity to contributed capitalAverage
Around the average of companies in the same industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityWeak
Among the 40% lowest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtStrong
Among the 30% highest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Annual reports & filings
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
LF Chief Executive Officer | Chief Executive Officer | 2015 |
LH Deputy | Deputy | 2026 |
HT Founder | Founder | 1986 |
DA Founder | Founder | 1986 |
MT Deputy | Deputy | 2026 |
PV Founder | Founder | 1986 |
Former (26)
| Deputy | 1986 – 1990 | |
AT Deputy | Deputy | 2014 – 2018 |
DP Deputy | Deputy | 2002 – 2005 |
MS Deputy | Deputy | 2014 – 2018 |
LT Deputy | Deputy | 2006 – 2010 |
KH | Deputy | 2022 – 2025 |
JS Deputy | Deputy | 1986 – 1998 |
CB | Deputy | 1986 – 1991 |
DT Deputy | Deputy | 2002 – 2006 |
MB Deputy | Deputy | 2018 – 2022 |
BF Deputy | Deputy | 2002 – 2003 |
LB Deputy | Deputy | 1998 – 2000 |
HN Deputy | Deputy | 1998 – 2000 |
KF Management | Management | 1986 – 2005 |
GN Deputy | Deputy | 1986 – 1990 |
RS Deputy | Deputy | 2014 – 2015 |
TM Deputy | Deputy | 1986 – 1996 |
HE Deputy | Deputy | 1986 – 1994 |
LØ Deputy | Deputy | 2010 – 2014 |
| Deputy | 2022 – 2023 | |
KA Deputy | Deputy | 1997 – 1997 |
DA Chief Executive Officer | Chief Executive Officer | 2015 – 2015 |
IL Deputy | Deputy | 1986 – 1989 |
OS Deputy | Deputy | 2018 – 2022 |
JA Chief Executive Officer | Chief Executive Officer | 2006 – 2015 |
IF Deputy | Deputy | 2006 – 2010 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
AC Deputy Chairman | Deputy Chairman | 2024 |
SC Board of Directors | Board of Directors | 2026 |
DP Board of Directors | Board of Directors | 2026 |
JH Board of Directors | Board of Directors | 2022 |
LP Chairman | Chairman | 2025 |
LO Board of Directors | Board of Directors | 2024 |
Former (66)
CV Board of Directors | Board of Directors | 1986 – 1998 |
AT Board of Directors | Board of Directors | 2006 – 2014 |
DC Board of Directors | Board of Directors | 2021 – 2024 |
OS Chairman | Chairman | 1986 – 1991 |
TB Board of Directors | Board of Directors | 2014 – 2022 |
MS Board of Directors | Board of Directors | 2010 – 2014 |
SL Board of Directors | Board of Directors | 2013 – 2021 |
KP Board of Directors | Board of Directors | 2002 – 2010 |
VC Board of Directors | Board of Directors | 1986 – 1994 |
KH Board of Directors | Board of Directors | 2025 – 2026 |
MB Board of Directors | Board of Directors | 2022 – 2025 |
KS Board of Directors | Board of Directors | 1986 – 1989 |
KP Board of Directors | Board of Directors | 1999 – 2006 |
VH Board of Directors | Board of Directors | 2012 – 2018 |
SE Board of Directors | Board of Directors | 1986 – 2014 |
DT Board of Directors | Board of Directors | 1986 – 1989 |
UP Chairman | Chairman | 2022 – 2024 |
LH Board of Directors | Board of Directors | 2022 – 2026 |
MB Board of Directors | Board of Directors | 2014 – 2018 |
AA Board of Directors | Board of Directors | 1986 – 1995 |
BW Deputy Chairman | Deputy Chairman | 2014 – 2022 |
VR Deputy Chairman | Deputy Chairman | 2007 – 2015 |
BF Board of Directors | Board of Directors | 2003 – 2010 |
PL Board of Directors | Board of Directors | 1997 – 1998 |
HN Board of Directors | Board of Directors | 2000 – 2002 |
PW Chairman | Chairman | 1999 – 2000 |
JA Board of Directors | Board of Directors | 2006 – 2014 |
RS Board of Directors | Board of Directors | 2015 – 2025 |
HT Board of Directors | Board of Directors | 1986 – 1990 |
CL Board of Directors | Board of Directors | 2019 – 2020 |
GA Board of Directors | Board of Directors | 1996 – 1999 |
LC Chairman | Chairman | 1999 – 1999 |
LL Deputy Chairman | Deputy Chairman | 2022 – 2024 |
LH Board of Directors | Board of Directors | 2018 – 2020 |
JG Chairman | Chairman | 2015 – 2020 |
TA Chairman | Chairman | 2024 – 2025 |
KP Board of Directors | Board of Directors | 1998 – 2003 |
IG Board of Directors | Board of Directors | 1986 – 1995 |
BK Deputy Chairman | Deputy Chairman | 2006 – 2007 |
OK Chairman | Chairman | 2000 – 2003 |
PJ Board of Directors | Board of Directors | 1986 – 1994 |
KA Board of Directors | Board of Directors | 1997 – 2000 |
LE Board of Directors | Board of Directors | 1986 – 1998 |
AR Board of Directors | Board of Directors | 1986 – 2002 |
AC Board of Directors | Board of Directors | 1998 – 1999 |
MJ Board of Directors | Board of Directors | 2001 – 2003 |
DA Chairman | Chairman | 2003 – 2004 |
IL Board of Directors | Board of Directors | 1986 – 1990 |
BK Chairman | Chairman | 1986 – 1997 |
PT Board of Directors | Board of Directors | 1986 – 1990 |
BB Deputy Chairman | Deputy Chairman | 2000 – 2006 |
JT Board of Directors | Board of Directors | 2002 – 2006 |
YN Board of Directors | Board of Directors | 1986 – 1996 |
AK Chairman | Chairman | 2004 – 2015 |
AM Board of Directors | Board of Directors | 2010 – 2015 |
OS Board of Directors | Board of Directors | 1986 – 1994 |
PV Board of Directors | Board of Directors | 1986 – 1991 |
PB Board of Directors | Board of Directors | 1986 – 1996 |
PS Board of Directors | Board of Directors | 2000 – 2002 |
LC Board of Directors | Board of Directors | 1986 – 1990 |
HB Board of Directors | Board of Directors | 1996 – 1997 |
RH Board of Directors | Board of Directors | 2010 – 2013 |
JK Board of Directors | Board of Directors | 1986 – 1990 |
PK Board of Directors | Board of Directors | 1986 – 1996 |
AD Board of Directors | Board of Directors | 2021 – 2022 |
ND Board of Directors | Board of Directors | 1986 – 1993 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 100% | 100% | 1996 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Related companies
Company hierarchy
Danmarks Apotekerforening
Pharmakon A/S Board network connections
Board members of Pharmakon A/S also hold positions in 80 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Pram Olsen | Chairman | 7 companiesMany roles |
| Lise Larsen | Deputy Chairman | 5 companies |
| Tue Askaa | Chairman | 5 companies |
| Annelise Christiansen | Board of Directors | 5 companies |
| Vinnie Rye Krogh | Deputy Chairman | 4 companies |
| Jeanette Hovgaard Rasmussen | Board of Directors | 4 companies |
| Lars Clemmensen | Board of Directors | 4 companies |
| Ann-Mari Damholt Grønbæk | Board of Directors | 4 companies |
| Christine Bruun Brandborg | Deputy | 3 companies |
| Dan Asmussen | Chief Executive Officer | 3 companies |
| Ole Søhøj Nielsen | Deputy | 3 companies |
| Ute Pørksen | Chairman | 3 companies |
| Bente Wittrup Præstbrogaard | Deputy Chairman | 3 companies |
| Jeanette Abel | Board of Directors | 3 companies |
| Jesper Gulev Larsen | Chairman | 3 companies |
| Bodil Brock | Deputy Chairman | 3 companies |
| Helle Nielsen | Deputy | 2 companies |
| Steffen Laursen Bager | Board of Directors | 2 companies |
| Vivian Henriette Zederkof | Board of Directors | 2 companies |
| Lars Orup Andersen | Board of Directors | 2 companies |
| Paul Bundgaard | Board of Directors | 2 companies |
| Dorit Petersen Møller | Deputy | 1 company |
| Kirsten Holme Christensen | Deputy | 1 company |
| Morten Topp | Deputy | 1 company |
| Janne Albertsen | Chief Executive Officer | 1 company |
| Dorte Clausen | Board of Directors | 1 company |
| Ole Stjärnqvist | Chairman | 1 company |
| Kaj Skytte Aarslev | Board of Directors | 1 company |
| Anja Claudia Hoffmann | Deputy Chairman | 1 company |
Frequently asked questions
What is the CVR number of Pharmakon A/S?
Pharmakon A/S is registered with CVR / Virk under CVR 10038839.
What is the revenue of Pharmakon A/S?
Pharmakon A/S reported revenue of DKK 143.5m in 2025.
How many employees does Pharmakon A/S have?
Pharmakon A/S employs 171 people as of the latest annual report.
Who is the CEO of Pharmakon A/S?
Lotte Fonnesbæk is the CEO of Pharmakon A/S, in role since 2015.
Who is the chairman of Pharmakon A/S?
Lars Pram Olsen chairs the board of Pharmakon A/S, in role since 2025.
Where is Pharmakon A/S headquartered?
Pharmakon A/S's registered address is Milnersvej 42.